The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development

American Heart Journal

Volumn 165, Issue 4, 2013, Pages 489-500

  Nada, Adel ^a   Gintant, Gary A ^b   Kleiman, Robert ^c   Gutstein, David E ^d   Gottfridsson, Christer ^e   Michelson, Eric L ^f   Strnadova, Colette ^g   Killeen, Matthew ^h   Geiger, Mary Jane ⁱ   Fiszman, Mónica L ^j   Koplowitz, Luana Pesco ^k   Carlson, Glenn F ^f   Rodriguez, Ignacio ^l   Sager, Philip T ^m  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b ABBVIE INC   (United States)

^c ERT   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e ASTRAZENECA R AND D   (Sweden)

^f ASTRAZENECA   (United Kingdom)

^g HEALTH CANADA   (Canada)

^h Decision Resources   (United States)

ⁱ Vifor (International) Inc   (Switzerland)

^j CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^k Duck Flats Pharma   (United States)

^l HOFFMANN LA ROCHE INC   (United States)

^m Sager Expert Consulting   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMIODARONE; ARSENIC TRIOXIDE; ATAZANAVIR; DIGOXIN; DISOPYRAMIDE; DOLASETRON MESILATE; ENCAINIDE; FINGOLIMOD; FLECAINIDE; HARKOSERIDE; LOPINAVIR PLUS RITONAVIR; MEFLOQUINE; MORACIZINE; PLACEBO; PREGABALIN; PROCAINAMIDE; PROPAFENONE; SAQUINAVIR; VERAPAMIL;

ARTICLE; ATRIOVENTRICULAR CONDUCTION; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COMPARATIVE STUDY; ELECTROCARDIOGRAM; HEART BUNDLE BRANCH BLOCK; HEART CONDUCTION; HEART MUSCLE; HEART VENTRICLE CONDUCTION; HUMAN; PR INTERVAL; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX;

EID: 84875443952     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.01.011     Document Type: Review

References (69)

1. D. Zeltser, D. Justo, and A. Halkin Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug J Am Coll Cardiol 44 2004 105 108
2. D. Mymin, F.A. Mathewson, R.B. Tate, and J. Manfreda The natural history of primary first-degree atrioventricular heart block N Engl J Med 315 1986 1183 1187
3. J.M. Packard, J.S. Graettinger, and A. Graybiel Analysis of the electrocardiograms obtained from 1000 young healthy aviators; ten year follow-up Circulation 10 1954 384 400
4. J. Erikssen, and J.E. Otterstad Natural course of a prolonged PR interval and the relation between PR and incidence of coronary heart disease. A 7-year follow-up study of 1832 apparently healthy men aged 40-59 years Clin Cardiol 7 1984 6 13
5. S. Cheng, M.J. Keyes, and M.G. Larson Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block JAMA 301 2009 2571 2577
6. R.K. Crisel, R. Farzaneh-Far, B. Na, and M.A. Whooley First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study Eur Heart J 32 2011 1875 1880
7. P. Kligfield, L.S. Gettes, and J.J. Bailey Recommendations for the standardization and interpretation of the electrocardiogram: part I: The electrocardiogram and its technology: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology Circulation 115 2007 1306 1324
8. P.E. Dilaveris, P. Farbom, V. Batchvarov, A. Ghuran, and M. Malik Circadian behavior of P-wave duration, P-wave area, and PR interval in healthy subjects Ann Noninvasive Electrocardiol 6 2001 92 97
9. M. Malik, K. Hnatkova, M. Sisakova, and G. Schmidt Subject-specific heart rate dependency of electrocardiographic QT, PQ, and QRS intervals J Electrocardiol 41 2008 491 497
10. B. Strasberg, Y.L.F. Amat, and R.C. Dhingra Natural history of chronic second-degree atrioventricular nodal block Circulation 63 1981 1043 1049
11. A. Venerando, and V. Rulli Frequency Morphology and Meaning of the Electrocardiographic Anomalies Found in Olympic Marathon Runners and Walkers J Sports Med Phys Fitness 50 1964 135 141
12. I. Meytes, E. Kaplinsky, J.H. Yahini, N. Hanne-Paparo, and H.N. Neufeld Wenckebach A-V block: a frequent feature following heavy physical training Am Heart J 90 1975 426 430
13. J.W. Mason, D.J. Ramseth, D.O. Chanter, T.E. Moon, D.B. Goodman, and B. Mendzelevski Electrocardiographic reference ranges derived from 79,743 ambulatory subjects J Electrocardiol 40 2007 228 234
14. A. Nada The expected variability of key ECG based parameters in healthy volunteers: implications for clinical relevance and regulatory thresholds of concern Paper presented at: Annual Phase I Club Meeting; 31 March; Paris, France 2010
15. R.C. Dhingra, P. Denes, D. Wu, R. Chuquimia, and K.M. Rosen The significance of second degree atrioventricular block and bundle branch block. Observations regarding site and type of block Circulation 49 1974 638 646
16. J.C. Stinson, J.S. Pears, A.J. Williams, and R.W. Campbell Use of 24 h ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers Br J Clin Pharmacol 39 1995 651 656
17. A. Nada PR interval prolongation and atrioventricular block related issues Paper presented at: CBT 5th Cardiac Safety Assessment Summit; 26-27 January; Alexandria, VA, USA 2011
18. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
19. A.L. Wit, and P.F. Cranefield Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia Circ Res 35 1974 413 425
20. R.J. Hariman, L.M. Mangiardi, R.G. McAllister Jr., B. Surawicz, R. Shabetai, and H. Kishida Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses Circulation 59 1979 797 804
21. R.G. McAllister Jr., D.W. Bourne, and L.W. Dittert The pharmacology of verapamil I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram J Pharmacol Exp Ther 202 1977 38 44
22. M.H. Husaini, J. Kvasnicka, L. Ryen, and S. Holmberg Action of verapamil on sinus node, atrioventricular, and intraventricular conduction Br Heart J 35 1973 734 737
23. M. Sakurai, H. Yasuda, and N. Kato Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia Am Heart J 105 1983 619 628
24. M. Miller, and H. Adams Antiarrhythmic drugs J. Riviere, M. Panich, Veterinary 2009 Wiley-Blackwell Pharmacology & Therapeutics
25. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm? fuseaction=Search.Overview&DrugName=LYRICA. Accessed November 10, 2012.
26. D.G. Strauss, and R.H. Selvester The QRS complex - a biomarker that "images" the heart: QRS scores to quantify myocardial scar in the presence of normal and abnormal ventricular conduction J Electrocardiol 42 2009 85 96
27. C. Fisch, D.P. Zipes, and P.L. McHenry Rate dependent aberrancy Circulation 48 1973 714 724
28. D.A. Chilson, D.P. Zipes, J.J. Heger, K.F. Browne, and E.N. Prystowsky Functional bundle branch block: discordant response of right and left bundle branches to changes in heart rate Am J Cardiol 54 1984 313 316
29. H. Hertzeanu, L. Aron, R.J. Shiner, and J. Kellermann Exercise dependent complete left bundle branch block Eur Heart J 13 1992 1447 1451
30. S. Kurl, T.H. Mäkikallio, P. Rautaharju, V. Kiviniemi, and J.A. Laukkanen Duration of QRS complex in resting electrocardiogram is a predictor of sudden cardiac death in men Circulation 125 2012 2588 2594
31. S. Cheng, M.G. Larson, and M.J. Keyes Relation of QRS width in healthy persons to risk of future permanent pacemaker implantation Am J Cardiol 106 2010 668 672
32. A.D. Desai, T.S. Yaw, T. Yamazaki, A. Kaykha, S. Chun, and V.F. Froelicher Prognostic significance of quantitative QRS duration Am J Med 119 2006 600 606
33. R. Sandhu, and R.C. Bahler Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction Am J Cardiol 93 2004 244 246
34. W. Shamim, M. Yousufuddin, M. Cicoria, D.G. Gibson, A.J. Coats, and M.Y. Henein Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure Heart 88 2002 47 51
35. W. Shamim, D.P. Francis, and M. Yousufuddin Intraventricular conduction delay: a prognostic marker in chronic heart failure Int J Cardiol 70 1999 171 178
36. G. Sumner, O. Salehian, and Q. Yi The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial J Cardiovasc Electrophysiol 20 2009 781 787
37. M.F. El-Chami, C. Brancato, and J. Langberg QRS duration is associated with atrial fibrillation in patients with left ventricular dysfunction Clin Cardiol 33 2010 132 138
38. F. Baslaib, S. Alkaabi, and A.T. Yan QRS prolongation in patients with acute coronary syndromes Am Heart J 159 2010 593 598
39. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary Eur Heart J 27 2006 2099 2140
40. P.M. Okin, R.B. Devereux, S.E. Kjeldsen, J.M. Edelman, and B. Dahlof Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study J Hypertens 27 2009 2271 2277
41. A.E. Epstein, A.P. Hallstrom, and W.J. Rogers Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST) JAMA 270 1993 2451 2455
42. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators N Engl J Med 321 1989 406 412
43. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators N Engl J Med 327 1992 227 233
44. R.S. Crow, P.J. Hannan, and A.R. Folsom Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up Circulation 108 2003 1985 1989
45. A.A. Rodriguez-Menchaca, R.A. Navarro-Polanco, and T. Ferrer-Villada The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel Proc Natl Acad Sci U S A 105 2008 1364 1368
46. K.J. Hellestrand, A.W. Nathan, R.S. Bexton, and A.J. Camm Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds Am J Cardiol 53 1984 30B 38B
47. B. Surawicz, R. Childers, and B.J. Deal AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology J Am Coll Cardiol 53 2009 976 981
48. C.D. Dota, N. Edvardsson, and K.M. Schutzer Inter- and intraday variability in major electrocardiogram intervals and amplitudes in healthy men and women Pacing Clin Electrophysiol 26 2003 361 366
49. R.I. Harris, and S.E. Steare A meta-analysis of ECG data from healthy male volunteers: diurnal and intra-subject variability, and implications for planning ECG assessments and statistical analysis in clinical pharmacology studies Eur J Clin Pharmacol 62 2006 893 903
50. B.J. Schijvenaars, G. van Herpen, and J.A. Kors Intraindividual variability in electrocardiograms J Electrocardiol 41 2008 190 196
51. M. De Guillebon, J.B. Thambo, and S. Ploux Reliability and reproducibility of QRS duration in the selection of candidates for cardiac resynchronization therapy J Cardiovasc Electrophysiol 21 2010 890 892
52. M.C. de Bruyne, J.A. Kors, and S. Visentin Reproducibility of computerized ECG measurements and coding in a nonhospitalized elderly population J Electrocardiol 31 1998 189 195
53. J.D. Dougherty, and H.W. Stoudt The relation of frontal QRS axis to age and body build J Electrocardiol 3 1970 285 298
54. E. Widerlov, K.G. Jostell, L. Claesson, B. Odlind, M. Keisu, and U. Freyschuss Influence of food intake on electrocardiograms of healthy male volunteers Eur J Clin Pharmacol 55 1999 619 624
55. J.D. Dougherty The relation of respiratory changes in the horizontal QRS and T-wave axes to movement of the thoracic electrodes J Electrocardiol 3 1970 77 85
56. L. Hondeghem, and B.G. Katzung Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction Circulation 61 1980 1217 1224
57. B.P. Bean, C.J. Cohen, and R.W. Tsien Lidocaine block of cardiac sodium channels J Gen Physiol 81 1983 613 642
58. S. Nattel Frequency-dependent effects of amitriptyline on ventricular conduction and cardiac rhythm in dogs Circulation 72 1985 898 906
59. R.H. Heissenbuttel, and J.T. Bigger Jr. The effect of oral quinidine on intraventricular conduction in man: correlation of plasma quinidine with changes in QRS duration Am Heart J 80 1970 453 462
60. S. Ranger, M. Talajic, R. Lemery, D. Roy, C. Villemaire, and S. Nattel Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans Circulation 83 1991 1987 1994
61. P.T. Sager, P. Uppal, C. Follmer, M. Antimisiaris, C. Pruitt, and B.N. Singh Frequency-dependent electrophysiologic effects of amiodarone in humans Circulation 88 1993 1063 1071
62. C.R. Benedict, R. Arbogast, L. Martin, L. Patton, B. Morrill, and W. Hahne Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers J Cardiovasc Pharmacol 28 1996 53 59
63. Y.A. Kuryshev, A.M. Brown, L. Wang, C.R. Benedict, and D. Rampe Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels J Pharmacol Exp Ther 295 2000 614 620
64. G.A. Gintant, D.J. Gallacher, and M.K. Pugsley The 'overly-sensitive' heart: sodium channel block and QRS interval prolongation Br J Pharm 164 2011 254 259
65. T. Sadanaga, and S. Ogawa Ischemia enhances use-dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent J Am Coll Cardiol 23 1994 1378 1381
66. H.R. Lu, J. Rohrbacher, and E. Vlaminckx Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the "bad" sodium current blockers Br J Pharmacol 160 2010 60 76
67. D.G. Spiker, A.N. Weiss, S.S. Chang, J.F. Ruwitch Jr., and J.T. Biggs Tricyclic antidepressant overdose: clinical presentation and plasma levels Clin Pharmacol Ther 18 1975 539 546
68. J.T. Biggs, D.G. Spiker, J.M. Petit, and V.E. Ziegler Tricyclic antidepressant overdose: incidence of symptoms JAMA 238 1977 135 138
69. S. Ayalasomayajula, C.M. Yeh, and S. Vaidyanathan Effects of aliskiren, a direct renin inhibitor, on cardiac repolarization and conduction in healthy subjects J Clin Pharmacol 48 2008 799 811